A model to predict cell-mediated immune regulatory mechanisms during human infection with Mycobacterium tuberculosis

Journal of Immunology

Volumn 166, Issue 3, 2001, Pages 1951-1967

  Wigginton, J E ^a   Kirschner, D ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4;

ARTICLE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; LUNG TUBERCULOSIS; MACROPHAGE ACTIVATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; TISSUE INJURY;

EID: 0035253576     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.3.1951     Document Type: Article

References (132)

1. Epidemiology of tuberculosis
2. Disruption of phagosomal membranes of normal alveolar macrophages by the H37Rv strain of Mycobacterium tuberculosis
3. Pathogenesis of tuberculosis: Interaction of Mycobacterium tuberculosis with macrophages
4. Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes and phagosomes
5. Induction of in vitro human macrophage anti-M. tuberculosis activity: Requirement for IFN-γ and primed lymphocytes
6. Heterogeneity of intracellular cytokine synthesis at the single cell level in polarized T helper 1 and T helper 2 populations
7. Commitment of individual Th1-like lymphocytes to expression of IFN-γ vs IL-4 and IL-10
8. Human T helper cell differentiation is regulated by the combined action of cytokines and accessory cell-dependent costimulatory signals
9. Roles of IL-4 and IFN-γ in stabilizing the T helper cell type 1 and 2 phenotype
10. Reciprocal regulatory effects of IFN-γ and IL-4 on the in vitro development of human Th1 and Th2 clones
11. + T cell clones use perforin- or Fas/Fas ligand-mediated pathways for target cell lysis
12. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis
13. + T cells use both CD95-dependent and CD95-independent cytolytic mechanisms
14. + cytotoxic T cells, and relative resistance of alveolar macrophages to lysis
15. + αβ T cell and γδ T cell responses to Mycobacterium tuberculosis
16. + cytotoxic T cells specific for macrophages infected with Mycobacterium tuberculosis
17. Human cytolytic and interferon γ-secreting T lymphocytes specific for Mycobacterium tuberculosis
18. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages, by release of TNF-R2, resulting in inactivation of TNF-α
19. TNF-α and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macrophages
20. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages
21. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency
22. Consequence of Nramp1 deletion to Mycobacterium tuberculosis infection in mice
23. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection
24. An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection
25. Interleukin-12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis
26. Absence of a prominent Th2 cytokine response in human tuberculosis
27. Mice incapable of making IL-4 and IL-10 display normal resistance in infection with Mycobacterium tuberculosis
28. In situ production of γ interferon, interleukin-4, and tumor necrosis factor α mRNA in human lung tuberculous granuloma
29. Mice deficient in CD4 T cells have only transiently diminished levels of IFNγ, yet succumb to tuberculosis
30. Reactivation of latent tuberculosis: Variations on the Cornell murine model
31. + T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice
32. Lymphocyte and lymphocyte subset numbers in blood and in bronchoalveolar lavage and pleural fluid in various forms of human pulmonary tuberculosis at presentation and during recovery
33. Correlation of CD4:CD8 ratio and tumour necrosis factor TNF-α levels in induced sputum with bronchoalveolar lavage fluid in pulmonary sarcoidosis
34. Tuberculosis in HIV-positive patients: Cellular response and immune activation in the lung
35. Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity
36. Activation of tuberculostatic macrophage functions by γ interferon, interleukin-4, and tumor necrosis factor
37. Antigen-specific activation of effector macrophages by IFN-γ producing Th1 T cell clones
38. IL-10 downregulates MHC class II αβ peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling
39. IL-10 inhibits parasite killing and nitrogen oxide production by IFNγ-activated macrophages
40. T-cell derived IL-10 antagonizes macrophage function in mycobacterial infection
41. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase
42. Identification and characterization of peptides that modulate the growth of Mycobacterium tuberculosis
43. Interleukin 10 and viral IL-I0 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II MHC complex expression
44. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production
45. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
46. IL-10 inhibits cytokine production by activated macrophages
47. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
48. Cytokine production at the site of disease in human tuberculosis
49. + T cells in response to monocytes infected with Mycobacterium tuberculosis-H37Ra
50. Interaction of Mycobacterium tuberculosis-induced transforming growth factor β1 and interleukin-10
51. IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses
52. Interleukin 12 and B7/CD28 interaction synergistically upregulate IL-10 production by human T cells
53. + T cell clones and peripheral blood T cell
54. Regulation of interleukin-12 by interleukin-10, transforming growth factor-β, tumor necrosis factor-α, and interferon-γ in human monocytes infected with Mycobacterium tuberculosis H37Ra
55. Interleukin-12 secretion by Mycobacterium tuberculosis-infected macrophages
56. Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: Role of phagocytosis
57. Interleukin-12 production by human alveolar macrophages is controlled by the autocrine production of interleukin-10
58. In vivo regulation of macrophage IL-12 production during type 1 and type 2 cytokine-mediated granuloma formation
59. Natural killer cell stimulatory factor (interleukin 12 (IL-12)) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells
60. + T cells analyzed at the single cell level
61. Cytokines induce the development of functionally heterogeneous T helper cell subsets
62. Role of IL-12 in the induction and potentiation of IFNγ in response to bacillus Calmette-Guérin
63. Regulation of the IL-12R β2 subunit expression in developing Th1 and Th2 cells
64. Differential potentiation of antimycobacterial activity and reactive nitrogen intermediate-producing ability of murine peritoneal macrophages activated by interferon-γ and tumor necrosis factor α
65. Increased release of interleukin-1β, interleukin-6, and tumor necrosis factor-α by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis
66. Local immune responses correlate with presentation and outcome in tuberculosis
67. Recruitment of inflammatory cells to the pleural space
68. Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis
69. + T cell clones producing both interferon-γ and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients
70. Effects of aerosolized interferon-α in patients with pulmonary tuberculosis
71. Cytokine levels correlate with a radiologic score in active pulmonary tuberculosis
72. Disseminated tuberculosis in IFN-γ gene disrupted mice
73. Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Guérin in IL-12 deficient mice
74. Type 2 cytoken gene activation and its relationship to extent of disease in patients with tuberculosis
75. + T cells from patients with tuberculosis is related to the presence of pulmonary cavities
76. IFN-γ and IL-12 are increased in active compared to inactive tuberculosis
77. T-cell cytokine responses in human infection with Mycobacterium tuberculosis
78. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection
79. Interferon γ receptor deficiency in an infant with fatal Bacille Calmette Guérin infection
80. Increased antimycobacterial immunity in interleukin-10 deficient mice
81. Interleukin-10 downregulates Mycobacterium tuberculosisinduced Th1 responses and CTLA-4 expression
82. Protection by CD4 or CD8 T cells against pulmonary Mycobacterium bovis bacillus Calmette-Guérin infection
83. + T cells
84. Tumor necrosis factor-α is required in the protective immune response to Mycobacterium tuberculosis in mice
85. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection which is not compensated for by lymphotoxin
86. The role of the thymus in pediatric HIV-1 infection
87. + lymphocytes
88. + T lymphocytes in bronchoalveolar lavage fluid in pulmonary sarcoidosis
89. Clinical role of bronchoalveolar lavage in adults with pulmonary disease
90. Yield of gastric lavage and bronchial wash in pulmonary tuberculosis
91. Modeling the proliferative response of T cells to IL-2 and IL-4
92. Th1/Th2 cross regulation
93. On the role of feedback in promoting conflicting goals of the adaptive immune system
94. Modeling immune responses with handling time
95. Dynamics of coinfection with M. tuberculosis and HIV-1
96. Theoretical and experimental approaches for studying factors defining the Helicobacter pylori-host relationship
97. Reconstructionist molecular biology
98. Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers
99. Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers
100. Expression of virulence of Mycobacterium tuberculosis within human monocytes: Virulence correlates with intracellular growth and induction of tumor necrosis factor-α but not with evasion of lymphocyte-dependent monocyte effector functions
101. + T cells in purified protein-positive, but not in purified protein derivative-negative subjects
102. Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages
103. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates
104. Comparable growth of virulent and avirulent Mycobacterium tuberculosis in human macrophages in vitro
105. Mycobacterial virulence: Virulent strains of Mycobacterium tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity
106. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection
107. Interleukin 12 at the site of disease in human tuberculosis
108. Interleukin 10 inhibits human lymphocyte IFN-γ production by suppressing natural killer cell stimulatory factor/IL-12 release
109. Lifespan of lymphocytes
110. Circulating T and B lymphocytes of the mouse: Lifespans
111. Lifespans of naive, memory and effector lymphocytes
112. Interleukin-8 induces lymphocyte chemotaxis into the pleura] space
113. Dysregulated production of interleukin 8 in individuals infected with human immunodeficiency virus type 1 and Mycobacterium tuberculosis
114. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages
115. Apoptosis of human monocytes in Mycobacterium tuberculosis infection
116. Differential induction of apoptosis by virulent Mycobacterium tuberculosis in resistant and susceptible murine macrophages
117. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis
118. Specific lysis of mycobacterial antigen-bearing macrophages by class II MHC-restricted polyclonal T cell lines in healthy donors or patients with tuberculosis
119. + CTL from lungs of Mycobacterium tuberculosis-infected mice express perforin in vivo and lyse infected macrophages
120. Cytokine activation leads to acidification and increases in maturation of Mycobacterium avium complex containing phagosomes in murine macrophages
121. Complement receptor-mediated uptake and tumor necrosis factor-α-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages
122. Interleukin 10 produced by macrophages inoculated with Mycobacterium avium attenuates mycobacteria-induced apoptosis by reduction of TNF-α activity
123. Pharmacokinetics, single-dose tolerance, and biological activity of recombinant γ-interferon in cancer patients
124. Enhanced capacity of a wide spread strain of Mycobacterium tuberculosis to grow in human macrophages
125. Distribution of lymphocyte subsets and natural killer cells in the human body
126. Interferon-γ inhibits interleukin 10 production by monocytes
127. Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis
128. Quantitative study on the production and kinetics of mononuclear phagocytes during an acute inflammatory reaction